Marion General Hospital, INC.
Marion General Hospital, INC. was paid $36.47M by Medicaid between Jan 2018 and Dec 2024, across 312 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 17% of everything it billed.
MARION, OH 43302
Next to other General Acute Care Hospital providers in Ohio
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 115,430 | $3.76M | |
| 2019 | 108,270 | $3.33M | |
| 2020 | 82,206 | $3.34M | |
| 2021 | 91,209 | $3.63M | |
| 2022 | 104,967 | $4.00M | |
| 2023 | 300,415 | $10.89M | |
| 2024incomplete | 193,589 | $7.52M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 17% | 21,397 | 15,113 | $6.09M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 44,454 | 40,953 | $5.19M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 39,202 | 34,750 | $5.05M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.9% | 21,762 | 18,659 | $2.90M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.4% | 8,227 | 6,975 | $1.96M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.2% | 15,695 | 14,612 | $1.55M |
| 70450 | Computed tomography, head or brain; without contrast material | 4.1% | 6,545 | 5,572 | $1.51M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.6% | 15,938 | 4,956 | $944K |
| G0378 | Hospital observation service, per hour | 2.1% | 13,728 | 5,096 | $760K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.6% | 4,948 | 3,294 | $585K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.5% | 2,743 | 2,116 | $555K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.3% | 1,735 | 1,365 | $461K |
300 more codes
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 1.1% | 5,670 | $397K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 3,414 | $390K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.1% | 1,697 | $389K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,775 | $356K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 909 | $349K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 4,695 | $326K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,409 | $307K |
| 80053 | Comprehensive metabolic panel | <1% | 36,364 | $299K |
| 59025 | Fetal non-stress test | <1% | 1,948 | $242K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,433 | $226K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 539 | $221K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 11,315 | $193K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 28,925 | $172K |
| 93976 | <1% | 1,206 | $161K | |
| 95806 | <1% | 307 | $160K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 861 | $136K |
| 64493 | <1% | 285 | $122K | |
| 84484 | <1% | 24,921 | $116K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,391 | $114K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 212 | $113K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 704 | $105K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 6,967 | $105K |
| 97113 | <1% | 1,608 | $104K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 281 | $96K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,151 | $93K |
| 95811 | <1% | 153 | $93K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 366 | $86K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,690 | $85K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 84 | $78K |
| 97162 | <1% | 1,986 | $77K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 549 | $76K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,921 | $72K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 2,244 | $65K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 125 | $64K |
| 72100 | <1% | 1,520 | $63K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 539 | $61K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,284 | $61K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 652 | $60K |
| 71271 | <1% | 323 | $59K | |
| 70496 | <1% | 226 | $58K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 645 | $57K |
| 93017 | <1% | 725 | $57K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 66,690 | $57K |
| 97166 | <1% | 1,035 | $56K | |
| 82805 | <1% | 2,036 | $55K | |
| 71250 | <1% | 738 | $55K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,362 | $54K |
| 71045 | Radiologic examination, chest; single view | <1% | 22,887 | $49K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 258 | $47K |
| 12001 | <1% | 293 | $47K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 486 | $46K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 2,859 | $46K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,533 | $45K |
| J3490 | Unclassified drugs | <1% | 4,456 | $44K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 30,936 | $42K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 125 | $40K |
| 93971 | <1% | 601 | $39K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 71,934 | $39K |
| 97161 | <1% | 947 | $39K | |
| 76830 | Ultrasound, transvaginal | <1% | 848 | $39K |
| 76536 | <1% | 417 | $38K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 234 | $36K |
| 72141 | <1% | 250 | $36K | |
| 96367 | <1% | 560 | $36K | |
| 73030 | <1% | 1,235 | $35K | |
| 73130 | <1% | 1,243 | $35K | |
| 73110 | <1% | 911 | $35K | |
| 94060 | <1% | 367 | $34K | |
| 73610 | <1% | 1,190 | $34K | |
| 73630 | <1% | 1,320 | $33K | |
| 72040 | <1% | 622 | $33K | |
| 73564 | <1% | 519 | $32K | |
| 94726 | <1% | 574 | $31K | |
| 74018 | <1% | 798 | $30K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 27,667 | $29K |
| 72131 | <1% | 485 | $29K | |
| 36591 | <1% | 1,073 | $28K | |
| 76642 | <1% | 242 | $27K | |
| 94729 | <1% | 627 | $27K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,890 | $26K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 210 | $25K |
| 93970 | <1% | 190 | $23K | |
| 73560 | <1% | 1,303 | $23K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 557 | $23K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 9,864 | $23K |
| 73502 | <1% | 740 | $23K | |
| 97116 | <1% | 1,039 | $23K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 20,829 | $21K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,294 | $21K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,864 | $20K |
| 70486 | <1% | 336 | $20K | |
| 70491 | <1% | 79 | $19K | |
| 86900 | <1% | 1,495 | $18K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,071 | $17K |
| 73080 | <1% | 509 | $17K | |
| 80076 | <1% | 2,175 | $16K | |
| 85027 | <1% | 5,710 | $16K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,834 | $15K |
| 86850 | <1% | 1,393 | $15K | |
| 76801 | <1% | 462 | $14K | |
| 80061 | Lipid panel | <1% | 2,429 | $14K |
| 81001 | <1% | 34,790 | $13K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 10,090 | $13K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 37 | $13K |
| 73562 | <1% | 206 | $12K | |
| 72072 | <1% | 308 | $12K | |
| 97163 | <1% | 248 | $12K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 57 | $12K |
| 76770 | <1% | 63 | $12K | |
| 70498 | <1% | 241 | $11K | |
| 96376 | <1% | 4,663 | $11K | |
| 72050 | <1% | 259 | $11K | |
| 96415 | <1% | 37 | $11K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,740 | $11K |
| 12011 | <1% | 58 | $10K | |
| 85610 | <1% | 6,640 | $10K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 505 | $10K |
| 82607 | <1% | 1,192 | $10K | |
| 80069 | <1% | 1,264 | $10K | |
| 36416 | <1% | 1,365 | $9K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 998 | $9K |
| 73700 | <1% | 74 | $9K | |
| 80320 | <1% | 685 | $9K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 5,455 | $9K |
| 94010 | <1% | 103 | $8K | |
| 72110 | <1% | 184 | $8K | |
| 85379 | <1% | 1,948 | $8K | |
| 82248 | <1% | 17,692 | $8K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 998 | $8K |
| J3535 | Drug administered through a metered dose inhaler | <1% | 606 | $8K |
| 84439 | <1% | 1,053 | $8K | |
| 73590 | <1% | 411 | $7K | |
| 83690 | <1% | 21,774 | $7K | |
| 88307 | <1% | 51 | $7K | |
| 83880 | <1% | 2,534 | $7K | |
| 83735 | <1% | 6,081 | $7K | |
| 90715 | <1% | 452 | $7K | |
| 86703 | <1% | 420 | $7K | |
| 99152 | <1% | 635 | $7K | |
| C1726 | Catheter, balloon dilatation, non-vascular | <1% | 646 | $6K |
| 82728 | <1% | 789 | $6K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 846 | $6K |
| 84703 | <1% | 7,933 | $6K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 44 | $6K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 33 | $6K |
| 88341 | <1% | 90 | $6K | |
| 73090 | <1% | 268 | $5K | |
| 86901 | <1% | 1,495 | $5K | |
| 86140 | <1% | 788 | $5K | |
| 80051 | <1% | 5,105 | $5K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 4,308 | $5K |
| 84702 | <1% | 1,119 | $5K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 27 | $5K |
| 94618 | <1% | 70 | $4K | |
| 82077 | <1% | 2,741 | $4K | |
| J1815 | Injection, insulin, per 5 units | <1% | 1,678 | $4K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 13,126 | $4K |
| 83540 | <1% | 842 | $4K | |
| 87420 | <1% | 1,211 | $3K | |
| 87510 | <1% | 555 | $3K | |
| 82746 | <1% | 799 | $3K | |
| 88342 | <1% | 571 | $3K | |
| 83550 | <1% | 811 | $3K | |
| 86803 | <1% | 297 | $3K | |
| 87081 | <1% | 3,043 | $3K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 560 | $3K |
| 76377 | <1% | 833 | $3K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 459 | $3K |
| 87077 | <1% | 1,102 | $3K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 337 | $3K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 3,803 | $3K |
| 96417 | <1% | 88 | $3K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 17,702 | $2K |
| 96523 | <1% | 77 | $2K | |
| 72128 | <1% | 53 | $2K | |
| 73221 | <1% | 13 | $2K | |
| 87506 | <1% | 18 | $2K | |
| 73140 | <1% | 63 | $2K | |
| 74022 | <1% | 270 | $2K | |
| C1769 | Guide wire | <1% | 315 | $2K |
| 82570 | <1% | 636 | $2K | |
| 87480 | <1% | 555 | $2K | |
| 88304 | <1% | 786 | $2K | |
| 85007 | <1% | 921 | $2K | |
| 87186 | <1% | 1,007 | $2K | |
| 82565 | <1% | 5,222 | $2K | |
| 92523 | <1% | 18 | $2K | |
| 84153 | <1% | 272 | $2K | |
| 85652 | <1% | 799 | $2K | |
| 12002 | <1% | 12 | $2K | |
| 84100 | <1% | 974 | $2K | |
| 96368 | <1% | 74 | $2K | |
| 73060 | <1% | 109 | $2K | |
| 87070 | <1% | 550 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,273 | $1K |
| 73552 | <1% | 108 | $1K | |
| 87040 | <1% | 991 | $1K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 255 | $1K |
| 83605 | <1% | 1,382 | $1K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 2,347 | $1K |
| 82947 | <1% | 5,080 | $1K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 32 | $1K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 332 | $1K |
| 84520 | <1% | 5,089 | $1K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 6,613 | $1K |
| L4360 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 12 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 493 | $1K |
| 97802 | <1% | 12 | $1K | |
| 85730 | <1% | 670 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 12,092 | $942.61 |
| 87660 | <1% | 76 | $889.64 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 12 | $843.33 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,914 | $834.68 |
| J2704 | Injection, propofol, 10 mg | <1% | 8,063 | $824.87 |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | <1% | 112 | $810.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 412 | $799.96 |
| 84550 | <1% | 172 | $750.86 | |
| 87205 | <1% | 624 | $718.32 | |
| 72081 | <1% | 12 | $714.50 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 187 | $711.52 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 754 | $709.96 |
| 85018 | <1% | 1,809 | $705.97 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,141 | $679.98 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 350 | $677.00 |
| 82043 | <1% | 162 | $644.37 | |
| 86780 | <1% | 60 | $587.22 | |
| 29125 | <1% | 70 | $571.07 | |
| 82550 | <1% | 430 | $569.88 | |
| 83615 | <1% | 191 | $555.49 | |
| 83970 | <1% | 102 | $534.69 | |
| 86038 | <1% | 15 | $531.41 | |
| 97597 | <1% | 17 | $500.17 | |
| 86308 | <1% | 107 | $472.02 | |
| 80179 | <1% | 203 | $470.80 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 2,221 | $458.96 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 17,787 | $447.99 |
| 80143 | <1% | 182 | $402.50 | |
| 84156 | <1% | 259 | $392.94 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,828 | $356.30 |
| 81025 | <1% | 2,894 | $347.96 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 447 | $345.81 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 266 | $343.97 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,525 | $291.45 |
| 85014 | <1% | 168 | $286.76 | |
| 76870 | <1% | 12 | $276.37 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,805 | $273.75 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 390 | $266.12 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,994 | $243.92 |
| 87075 | <1% | 168 | $220.07 | |
| 71101 | <1% | 19 | $217.93 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,644 | $217.27 |
| 99406 | <1% | 15 | $216.60 | |
| 87340 | <1% | 27 | $209.84 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 259 | $191.68 |
| 82140 | <1% | 156 | $187.88 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,784 | $181.15 |
| J3360 | Injection, diazepam, up to 5 mg | <1% | 105 | $175.08 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 1,329 | $156.02 |
| 83655 | <1% | 14 | $146.48 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 750 | $130.13 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 157 | $103.73 |
| 20985 | <1% | 20 | $103.27 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 1,088 | $100.38 |
| 64494 | <1% | 264 | $99.04 | |
| 86592 | <1% | 36 | $97.78 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 121 | $94.01 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 1,380 | $88.65 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 275 | $72.42 |
| 82784 | <1% | 15 | $68.53 | |
| 84132 | <1% | 56 | $65.95 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 3,735 | $65.77 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 380 | $63.58 |
| 82270 | <1% | 35 | $54.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 635 | $51.79 |
| 87147 | <1% | 17 | $51.71 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 193 | $50.93 |
| 84460 | <1% | 32 | $48.08 | |
| J0736 | Injection, clindamycin phosphate, 300 mg | <1% | 61 | $46.71 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 143 | $45.40 |
| 80074 | <1% | 12 | $43.93 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | <1% | 39 | $40.32 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 262 | $39.32 |
| J2471 | Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg | <1% | 153 | $37.31 |
| 80178 | <1% | 18 | $32.57 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 84 | $31.97 |
| 82010 | <1% | 122 | $29.41 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 108 | $27.52 |
| 84450 | <1% | 17 | $20.50 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 206 | $18.40 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 101 | $14.41 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 31 | $12.43 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 124 | $12.15 |
| 81002 | <1% | 708 | $4.55 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 85 | $0.90 |
| 51701 | 0% | 60 | $0.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 595 | $0.00 |
| C9399 | Unclassified drugs or biologicals | 0% | 19 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 40 | $0.00 |
| J0173 | Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg | 0% | 19 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Ohiohealth Corporation | Columbus, OH | $214.99M |
| Ohiohealth Corporation | Columbus, OH | $76.95M |
| Ohiohealth Corporation | Columbus, OH | $72.29M |
| Ohiohealth Corporation | Columbus, OH | $44.08M |
| Medcentral Health System | Mansfield, OH | $36.92M |
| Sheltering Arms Hospital Foundation, INC. | Athens, OH | $26.88M |
| Ohiohealth Berger Hospital LLC | Circleville, OH | $16.38M |
| Ohiohealth Corporation | Dublin, OH | $11.81M |
| Grady Memorial Hospital | Delaware, OH | $9.51M |
| Hardin Memorial Hospital | Kenton, OH | $7.27M |
| Medcentral Health System | Mansfield, OH | $3.13M |
| Madison Family Health Corporation | London, OH | $1.03M |
| Marion General Hospital, INC. | Marion, OH | $683K |
| Medcentral Health System | Mansfield, OH | $477K |
| Sheltering Arms Hospital Foundation | Athens, OH | $435K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.